Restricted accessEditorialFirst published online 2018-06
A New Era in Continuous Glucose Monitoring: Food and Drug Administration Creates a New Category of Factory-Calibrated Nonadjunctive,Interoperable Class II Medical Devices
BlevinsTC, BodeBW, GargSK, et al.: Statement by the American Association of Clinical Endocrinologists Consensus Panel on continuous glucose monitoring. Endocr Pract, 2010; 16:730–745.
2.
GargSK, PottsRO, AckermanNR, et al.: Correlation of fingerstick blood glucose measurements with GlucoWatch biographer glucose results in young subjects with type 1 diabetes. Diabetes Care, 1999; 22:1708–1714.
3.
TamadaJA, GargS, JovanovicL, et al.: Noninvasive glucose monitoring: comprehensive clinical results. Cygnus Research Team. JAMA, 1999; 282:1839–1844.
4.
TierneyMJ, GargS, AckermanNR, et al.: Effect of acetaminophen on the accuracy of glucose measurements obtained with the GlucoWatch biographer. Diabetes Technol Ther, 2000; 2:199–207.
5.
ChaseHP, KimLM, OwenSL, et al.: Continuous subcutaneous glucose monitoring in children with type 1 diabetes. Pediatrics, 2001; 107:222–226.
6.
TierneyMJ, TamadaJA, PottsRO, et al.: Clinical evaluation of the GlucoWatch biographer: a continual, non-invasive glucose monitor for patients with diabetes. Biosens Bioelectron, 2001; 16:621–629.
7.
GargSK, HoffHK, ChaseHP: The role of continuous glucose sensors in diabetes care. Endocrinol Metab Clin North Am, 2004; 33:163–173.
8.
GargSK: Health impact from frequent and continuous glucose monitoring. Diabetes Technol Ther, 2004; 6:523–524.
9.
GargS, ZisserH, SchwartzS, et al.: Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial. Diabetes Care, 2006; 29:44–50.
10.
GargS, JovanovicL: Relationship of fasting and hourly blood glucose levels to HbA1c values: safety, accuracy, and improvements in glucose profiles obtained using a 7-day continuous glucose sensor. Diabetes Care, 2006; 29:2644–2649.
11.
BaileyTS, ZisserHC, GargSK: Reduction in hemoglobin A1C with real-time continuous glucose monitoring: results from a 12-week observational study. Diabetes Technol Ther, 2007; 9:203–210.
12.
GargSK, KellyWC, VoelmleMK, et al.: Continuous home monitoring of glucose: improved glycemic control with real-life use of continuous glucose sensors in adult subjects with type 1 diabetes. Diabetes Care, 2007; 30:3023–3025.
13.
GargSK, SmithJ, BeatsonC, et al.: Comparison of accuracy and safety of the SEVEN and the Navigator continuous glucose monitoring systems. Diabetes Technol Ther, 2009; 11:65–72.
14.
WelshJB, KaufmanFR, LeeSW: Accuracy of the Sof-sensor glucose sensor with the iPro calibration algorithm. J Diabetes Sci Technol, 2012; 6:475–476.
15.
BaileyTS, AhmannA, BrazgR, et al.: Accuracy and acceptability of the 6-day Enlite continuous subcutaneous glucose sensor. Diabetes Technol Ther, 2014; 16:277–283.
16.
DamianoER, McKeonK, El-KhatibFH, et al.: A comparative effectiveness analysis of three continuous glucose monitors: the Navigator, G4 Platinum, and Enlite. J Diabetes Sci Technol, 2014; 8:699–708.
17.
TalebN, EmamiA, SuppereC, et al.: Comparison of two continuous glucose monitoring systems, Dexcom G4 Platinum and Medtronic Paradigm Veo Enlite system, at rest and during exercise. Diabetes Technol Ther, 2016; 18:561–567.
18.
NakamuraK, BaloA: The accuracy and efficacy of the Dexcom G4 Platinum continuous glucose monitoring system. J Diabetes Sci Technol, 2015; 9:1021–1026.
19.
CalhounP, LumJ, BeckRW, KollmanC: Performance comparison of the medtronic sof-sensor and enlite glucose sensors in inpatient studies of individuals with type 1 diabetes. Diabetes Technol Ther, 2013; 15:758–761.
20.
EllisSL, NaikRG, GemperlineK, GargSK: Use of continuous glucose monitoring in patients with type 1 diabetes. Curr Diabetes Rev, 2008; 4:207–217.
21.
EllisSL, BookoutT, GargSK, IzuoraKE: Use of continuous glucose monitoring to improve diabetes mellitus management. Endocrinol Metab Clin North Am, 2007; 36Suppl 2:46–68.
22.
GargSK: The future of continuous glucose monitoring. Diabetes Technol Ther, 2009; 11Suppl 1:S1–S3.
23.
GargSK, VoelmleMK, GottliebP: Feasibility of 10-day use of a continuous glucose-monitoring system in adults with type 1 diabetes. Diabetes Care, 2009; 32:436–438.
24.
RodbardD, BaileyT, JovanovicL, et al.: Improved quality of glycemic control and reduced glycemic variability with use of continuous glucose monitoring. Diabetes Technol Ther, 2009; 11:717–723.
25.
GargSK, VoelmleM, GottliebPA: Time lag characterization of two continuous glucose monitoring systems. Diabetes Res Clin Pract, 2010; 87:348–353.
26.
GargSK, AkturkHK: Flash glucose monitoring: The future is here. Diabetes Technol Ther, 2017; 19(S2):S1–S3.
27.
AjjanRA: How can we realize the clinical benefits of continuous glucose monitoring?. Diabetes Technol Ther, 2017; 19(S2):S27–S36.
28.
HossU, BudimanES: Factory-calibrated continuous glucose sensors: the science behind the technology. Diabetes Technol Ther, 2017; 19(S2):S44–S50.
29.
MillerKM, FosterNC, BeckRW, et al.: Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry. Diabetes Care, 2015; 38:971–978.
GargSK, VoelmleMK, BeatsonCR, et al.: Use of continuous glucose monitoring in subjects with type 1 diabetes on multiple daily injections versus continuous subcutaneous insulin infusion therapy: a prospective 6-month study. Diabetes Care, 2011; 34:574–579.
32.
MoserEG, MorrisAA, GargSK: Emerging diabetes therapies and technologies. Diabetes Res Clin Pract, 2012; 97:16–26.
33.
BergenstalRM, AhmannAJ, BaileyT, et al.: Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP). Diabetes Technol Ther, 2013; 15:198–211.
34.
RodbardD, JovanovicL, GargSK: Responses to continuous glucose monitoring in subjects with type 1 diabetes using continuous subcutaneous insulin infusion or multiple daily injections. Diabetes Technol Ther, 2009; 11:757–765.
35.
GargSK, AkturkHK: The future of continuous glucose monitoring. Diabetes Technol Ther, 2017; 19(S3):S1–S2.
36.
RodbardD: Continuous glucose monitoring: a review of recent studies demonstrating improved glycemic outcomes. Diabetes Technol Ther, 2017; 19(S3):S25–S37.
37.
HughesJ, WelshJB, BhavarajuNC, et al.: Stability, accuracy, and risk assessment of a novel subcutaneous glucose sensor. Diabetes Technol Ther, 2017; 19(S3):S21–S24.
38.
BeckRW, RiddlesworthT, RuedyK, et al.: Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND randomized clinical trial. JAMA, 2017; 317:371–378.
39.
LindM, PolonskyW, HirschIB, et al.: Continuous glucose monitoring vs conventional therapy for glycemic control in adults with type 1 diabetes treated with multiple daily insulin injections: the GOLD randomized clinical trial. JAMA, 2017; 317:379–387.
40.
TamborlaneWV, BeckRW, BodeBW, et al.: Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med, 2008; 359:1464–1476.
41.
WeinstockRS, DuBoseSN, BergenstalRM, et al.: Risk factors associated with severe hypoglycemia in older adults with type 1 diabetes. Diabetes Care, 2016; 39:603–610.
42.
MaiaFF, AraujoLR: Efficacy of continuous glucose monitoring system (CGMS) to detect postprandial hyperglycemia and unrecognized hypoglycemia in type 1 diabetic patients. Diabetes Res Clin Pract, 2007; 75:30–34.
43.
SteckAK, DongF, TakiI, et al.: Early hyperglycemia detected by continuous glucose monitoring in children at risk for type 1 diabetes. Diabetes Care, 2014; 37:2031–2033.
44.
FonsecaVA, GrunbergerG, AnhaltH, et al.: Continuous glucose monitoring: a consensus conference of the American Association of Clinical Endocrinologists and American College of Endocrinology. Endocr Pract, 2016; 22:1008–1021.
45.
GarberAJ, AbrahamsonMJ, BarzilayJI, et al.: Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm—2017 executive summary. Endocr Pract, 2017; 23:207–238.
46.
KlonoffDC, BuckinghamB, ChristiansenJS, et al.: Continuous glucose monitoring: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab, 2011; 96:2968–2979.
47.
SchnellO, BarnardK, BergenstalR, et al.: Role of continuous glucose monitoring in clinical trials: Recommendations on reporting. Diabetes Technol Ther, 2017; 19:391-399.
48.
BergenstalRM, AhmannAJ, BaileyT, et al.: Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the ambulatory glucose profile. J Diabetes Sci Technol, 2013; 7:562–578.
49.
van BeersCA, DeVriesJH, KleijerSJ, et al.: Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial. Lancet Diabetes Endocrinol, 2016; 4:893–902.
GargSK, WeinzimerSA, TamborlaneWV, et al.: Glucose outcomes with the in-home use of a hybrid closed-loop insulin delivery system in adolescents and adults with type 1 diabetes. Diabetes Technol Ther, 2017; 19:155–163.
52.
BergenstalRM, GargS, WeinzimerSA, et al.: Safety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes. JAMA, 2016; 316:1407–1408.
53.
BergenstalRM, KlonoffDC, GargSK, et al.: Threshold-based insulin-pump interruption for reduction of hypoglycemia. N Engl J Med, 2013; 369:224–232.
54.
FDA authorizes first fully interoperable continuous glucose monitoring system, streamlines review pathway for similar devices. https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm602870.htm Accessed May14, 2018.
55.
FDA Executive Summary. https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/ClinicalChemistryandClinicalToxicologyDevicesPanel/UCM602657.pdf Accessed May14, 2018.
56.
KropffJ, ChoudharyP, NeupaneS, et al.: Accuracy and longevity of an implantable continuous glucose sensor in the PRECISE Study: A 180-day, prospective, multicenter, pivotal trial. Diabetes Care, 2017; 40:63–68.
57.
ChristiansenMP, KlaffLJ, BrazgR, et al.: A prospective multicenter evaluation of the accuracy of a novel implanted continuous glucose sensor: PRECISE II. Diabetes Technol Ther, 2018; 20:197–206.
58.
WadwaRP, LaffelLM, ShahVN, GargSK: Accuracy of a factory-calibrated, real-time continuous glucose monitoring system during 10 days of use in youth and adults with diabetes. Diabetes Technol Ther, 2018; 20:395–402.
59.
ShahVN, LaffelLM, WadwaRP, GargSK: Performance of a factory-calibrated, real-time continuous glucose monitoring system utilizing an automated sensor applicator. Diabetes Technol Ther, 2018; 20:428–433.
